These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24867331)

  • 1. SSRI or CRF antagonism partially ameliorate depressive-like behavior after adolescent social defeat.
    Bourke CH; Glasper ER; Neigh GN
    Behav Brain Res; 2014 Aug; 270():295-9. PubMed ID: 24867331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fluoxetine on CRF and CRF1 expression in rats exposed to the learned helplessness paradigm.
    Fernández Macedo GV; Cladouchos ML; Sifonios L; Cassanelli PM; Wikinski S
    Psychopharmacology (Berl); 2013 Feb; 225(3):647-59. PubMed ID: 22960774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the selective nonpeptide corticotropin-releasing factor receptor 1 antagonist antalarmin in the chronic mild stress model of depression in mice.
    Ducottet C; Griebel G; Belzung C
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun; 27(4):625-31. PubMed ID: 12787849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of Stress-Induced Social Interaction Deficits by Buprenorphine.
    Browne CA; Falcon E; Robinson SA; Berton O; Lucki I
    Int J Neuropsychopharmacol; 2018 Feb; 21(2):164-174. PubMed ID: 29020387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective corticotropin-releasing factor 1 receptor antagonist E2508 has potent antidepressant-like and anxiolytic-like properties in rodent models.
    Taguchi R; Shikata K; Furuya Y; Ino M; Shin K; Shibata H
    Behav Brain Res; 2016 Oct; 312():138-47. PubMed ID: 27297028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the CRF
    Wróbel A; Serefko A; Szopa A; Rojek K; Poleszak E; Skalicka-Woźniak K; Dudka J
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Aug; 390(8):769-774. PubMed ID: 28429110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute administration of fluoxetine increases social avoidance and risk assessment behaviors in a sex- and social stress-dependent manner in Syrian hamsters (Mesocricetus auratus).
    Grieb ZA; Voisin DA; Terranova JI; Norvelle A; Michopoulos V; Huhman KL; Albers HE
    Pharmacol Biochem Behav; 2022 Mar; 214():173353. PubMed ID: 35150728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism of corticotropin-releasing factor CRF
    Ferrer-Pérez C; Reguilón MD; Manzanedo C; Aguilar MA; Miñarro J; Rodríguez-Arias M
    Eur J Pharmacol; 2018 Mar; 823():87-95. PubMed ID: 29391155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine, not donepezil, reverses anhedonia, cognitive dysfunctions and hippocampal proteome changes during repeated social defeat exposure.
    Gottschalk MG; Mortas P; Haman M; Ozcan S; Biemans B; Bahn S
    Eur Neuropsychopharmacol; 2018 Jan; 28(1):195-210. PubMed ID: 29174946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral, neuroendocrine and serotonergic consequences of single social defeat and repeated fluoxetine pretreatment in the Lewis rat strain.
    Berton O; Durand M; Aguerre S; Mormède P; Chaouloff F
    Neuroscience; 1999; 92(1):327-41. PubMed ID: 10392854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LIMK1/2 in the mPFC Plays a Role in Chronic Stress-Induced Depressive-Like Effects in Mice.
    Gao TT; Wang Y; Liu L; Wang JL; Wang YJ; Guan W; Chen TT; Zhao J; Jiang B
    Int J Neuropsychopharmacol; 2020 Dec; 23(12):821-836. PubMed ID: 32827213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal treatment with fluoxetine reduces depressive behavior induced by forced swim in adult rats.
    Mendes-da-Silva C; de Souza SL; Barreto-Medeiros JM; de Freitas-Silva SR; Antunes DE; Cunha AD; Ribas VR; de França MF; Nogueira MI; Manhães-de-Castro R
    Arq Neuropsiquiatr; 2002 Dec; 60(4):928-31. PubMed ID: 12563382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant treatment outcome depends on the quality of the living environment: a pre-clinical investigation in mice.
    Branchi I; Santarelli S; Capoccia S; Poggini S; D'Andrea I; Cirulli F; Alleva E
    PLoS One; 2013; 8(4):e62226. PubMed ID: 23653679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor.
    Gehlert DR; Shekhar A; Morin SM; Hipskind PA; Zink C; Gackenheimer SL; Shaw J; Fitz SD; Sajdyk TJ
    Eur J Pharmacol; 2005 Feb; 509(2-3):145-53. PubMed ID: 15733549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of social defeat stress and fluoxetine treatment on neurogenesis and behavior in mice that lack zinc transporter 3 (ZnT3) and vesicular zinc.
    McAllister BB; Pochakom A; Fu S; Dyck RH
    Hippocampus; 2020 Jun; 30(6):623-637. PubMed ID: 31821659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The acute social defeat stress and nest-building test paradigm: A potential new method to screen drugs for depressive-like symptoms.
    Otabi H; Goto T; Okayama T; Kohari D; Toyoda A
    Behav Processes; 2017 Feb; 135():71-75. PubMed ID: 27939810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forced swimming test and fluoxetine treatment: in vivo evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes.
    Bianchi M; Moser C; Lazzarini C; Vecchiato E; Crespi F
    Exp Brain Res; 2002 Mar; 143(2):191-7. PubMed ID: 11880895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine attenuates stress-induced depressive-like behavior through modulation of hippocampal GAP43 and neurogenesis in male rats.
    Zavvari F; Nahavandi A; Goudarzi M
    J Chem Neuroanat; 2020 Jan; 103():101711. PubMed ID: 31705954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of corticotropin-releasing factor in the median raphe nucleus in relapse to alcohol.
    Lê AD; Harding S; Juzytsch W; Fletcher PJ; Shaham Y
    J Neurosci; 2002 Sep; 22(18):7844-9. PubMed ID: 12223536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II. Characterization in rodent models of stress-related disorders.
    Griebel G; Simiand J; Steinberg R; Jung M; Gully D; Roger P; Geslin M; Scatton B; Maffrand JP; Soubrié P
    J Pharmacol Exp Ther; 2002 Apr; 301(1):333-45. PubMed ID: 11907191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.